Symbicort is a pressurized metered dose inhaler used in patients with moderate to severe asthma who are at least 6 years old, and for chronic obstructive pulmonary disorder (COPD) who are at least
On January 2023, the FDA approved the use of Airsupra, a rescue combination inhaler containing albuterol and budesonide. Traditionally, the only class of drugs used in rescue inhalers are SABAs (short-acting beta agonists),
